Updates reflect current international standards for clinical trial quality, participant safety, and modern research conduct.
2 天on MSN
Analysis - Chinese drugmakers with big ambitions struggle to recruit staff for global expansion
By Andrew Silver and Bhanvi Satija SHANGHAI/LONDON, July 16 (Reuters) - Leading Chinese drugmakers with global ambitions such ...
New cloud-based platform is being developed to integrate artificial intelligence, automated quality control and healthcare data connectivity to support next-generation precision medicine workflows. Be ...
FLock.io has been spotlighted by the World Economic Forum (WEF)’s MINDS programme for two NHS trusts using its ...
The next phase of healthcare transformation will be defined not only by what we invent but also by how effectively we apply ...
Leading Chinese drugmakers with global ambitions such as Jiangsu Hengrui Pharmaceuticals and CanSino Biologics are struggling ...
Every leadership development industry in the world is organized around a premise that is becoming obsolete–the belief that ...
PACS Group earns a Hold rating due to strong fundamentals but a full valuation at 18x forward earnings. Learn more about PACS ...
The newest addition to the lineup of AKASA AI assistants enables coding teams to work with unparalleled comprehensiveness to improve case mix index and reduce denials SAN FRANCISCO, CA / ACCESSWIRE / ...
Robert J. Fontana, MD, and Kenneth D. Rothstein, MD, share how they deliver self-management education to patients with MASLD.
A model may perform exceptionally well and still lack the evidence package necessary to support regulatory review.
The main market opportunities lie in offering expert training for veterinary clinical trials, focusing on VICH GCP compliance, effective study management, and data integrity. This appeals to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果